CompletedNCT01402492
Buprenorphine With Naltrexone for Cocaine Use
About this title
Read the official source — NCT01402492Medication studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Los Angeles and 10 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateSeptember 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 302
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01402492
- Official title
Show the full official title
Cocaine Use Reduction With Buprenorphine (CURB)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles · San Francisco · Denver
8 more locations
- Washington D.C.
- Atlanta
- New York
- The Bronx
- Columbus
- Portland
- San Antonio
- Seattle
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, Los Angeles, a university.
Did this study involve medication?
Yes. The study involved medication, including Buprenorphine + Naltrexone and Placebo + Naltrexone.
Who was this study for?
Listed age limits: 18 years to 65 years.
